John Potthoff

Doer
DISC Type : ds

Chief Executive Officer at RQM+

Austin, Texas, United States

Overview

With over 30 years of experience, John leads RQM+ as CEO and serves as an Operating Partner at Linden Capital Partners, specializing in the MedTech and biotech industries. He holds a Ph. D. from The University of Texas at Austin and is a NACD Directorship Certified board member, known for successfully growing service-based companies.

Outside of his executive roles, John is an active reader of business publications and literature applicable to the life sciences. His academic background in Austin suggests a likely interest in University of Texas athletics and local culture.

He co-founded Elligo Health Research to solve a critical industry challenge: making clinical trials more accessible to patients and clinicians.

Personality Overview

Risk-Accepting

Deliberate Doer

Strategic Planner

They might take some time to make their mind up but once they do, they don't change it easily.  Reading between the lines and seeing beyond your words comes naturally to them. They exhibit a rare combination of being result-oriented but patient at the same time.

Topics They Care About

Global MedTech Services
As CEO of RQM+, he focuses on the entire MedTech product lifecycle, including regulatory, clinical trials, lab services, and reimbursement on a global scale.
AI in Life Sciences
Actively promotes and debuts new AI tools within his portfolio companies, highlighting a focus on leveraging technology for innovation and efficiency in the sector.
Clinical Trial Innovation
Co-founded Elligo Health Research, a company specifically designed to enable broader and more efficient participation in clinical trials by providing necessary infrastructure.

Media Appearances

John Potthoff Appointed New CEO of RQM+. Featured in Slice of Healthcare

See Now

John Potthoff named CEO of contract research organization RQM+. Featured in Pittsburgh Business Journal

See Now

John Potthoff Joins RQM+™ as CEO. Featured in RQM+ (official website)

See Now

Work History

5-2024
Chief Executive Officer at RQM+
8-2021
Board Member at RQM+
4-2025
Operating Partner at Linden Capital Partners
12-2023
Chairperson of the Board at Elligo Health Research
3-2016 - 12-2023
CEO at Elligo Health Research

Education

1992 - 1995
Doctor of Philosophy (Ph.D.) from The University of Texas at Austin
1989 - 1992
Master of Arts (M.A.) from The University of Texas at Austin

More Information

Social Presence :

Prographics :

Exp : 9 Location : Austin, Texas, United States Job Level : Leadership Designation : Chief Executive Officer at RQM+
URL has been copied!

Insights For Selling To John

During A Call Or A Meeting

DO's

  • Let them know of potential risks but suggest mitigation methods alongside
  • Suggest clear next steps with confidence, don't be vague or hesitant
  • Ask them at the end if they see a strong value prop in your product; expect an honest answer

DONT's

  • Avoid putting conscious effort into relationship-building
  • Don't take their patience for granted, avoid long-winding sermons
  • Don't go over them unless you are left with no other option

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with John is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from John

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will John move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can John take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And John

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.